Literature DB >> 23063570

IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients.

Melanie E Garrett, Manal F Abdelmalek, Allison Ashley-Koch, Michael A Hauser, Cynthia A Moylan, Herbert Pang, Anna Mae Diehl, Hans L Tillmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23063570      PMCID： PMC3601946          DOI： 10.1016/j.jhep.2012.09.035

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.

Authors:  Salvatore Petta; Stefania Grimaudo; Calogero Cammà; Daniela Cabibi; Vito Di Marco; Giusalba Licata; Rosaria Maria Pipitone; Antonio Craxì
Journal:  J Hepatol       Date:  2012-02-05       Impact factor: 25.083

2.  Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.

Authors:  Hans L Tillmann; Keyur Patel; Andrew J Muir; Cynthia D Guy; Josephine H Li; Xiang Qian Lao; Alexander Thompson; Paul J Clark; Stephen D Gardner; John G McHutchison; Jeanette J McCarthy
Journal:  J Hepatol       Date:  2011-04-14       Impact factor: 25.083

3.  Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

Authors:  Josephine H Li; Xiang Qian Lao; Hans L Tillmann; Jennifer Rowell; Keyur Patel; Alexander Thompson; Sunil Suchindran; Andrew J Muir; John R Guyton; Stephen D Gardner; John G McHutchison; Jeanette J McCarthy
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

4.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Patricia Belt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

5.  The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.

Authors:  Paul J Clark; Alexander J Thompson; Qianqian Zhu; David M Vock; Mingfu Zhu; Keyur Patel; Stephen A Harrison; Susanna Naggie; Dongliang Ge; Hans L Tillmann; Thomas J Urban; Kevin Shianna; Jacques Fellay; Zachary Goodman; Stephanie Noviello; Lisa D Pedicone; Nezam Afdhal; Mark Sulkowski; Janice K Albrecht; David B Goldstein; John G McHutchison; Andrew J Muir
Journal:  Dig Dis Sci       Date:  2012-04-29       Impact factor: 3.199

6.  Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

Authors:  P J Clark; A J Thompson; M Zhu; D M Vock; Q Zhu; D Ge; K Patel; S A Harrison; T J Urban; S Naggie; J Fellay; H L Tillmann; K Shianna; S Noviello; L D Pedicone; R Esteban; P Kwo; M S Sulkowski; N Afdhal; J K Albrecht; D B Goldstein; J G McHutchison; A J Muir
Journal:  J Viral Hepat       Date:  2012-02-22       Impact factor: 3.728

7.  Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease.

Authors:  José A Agúndez; Elena García-Martin; María L Maestro; Francisca Cuenca; Carmen Martínez; Luis Ortega; Miguel Carballo; Marta Vidaurreta; Marta Agreda; Gabriela Díaz-Zelaya; Avelina Suárez; Manuel Díaz-Rubio; José M Ladero
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240
  7 in total
  7 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?

Authors:  Enrico Galmozzi; Roberta D'Ambrosio
Journal:  Hepatobiliary Surg Nutr       Date:  2018-06       Impact factor: 7.293

Review 3.  Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.

Authors:  Hisamitsu Miyaaki; Kazuhiko Nakao
Journal:  Clin J Gastroenterol       Date:  2017-03-13

Review 4.  Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.

Authors:  Bratati Kahali; Brian Halligan; Elizabeth K Speliotes
Journal:  Semin Liver Dis       Date:  2015-12-16       Impact factor: 6.115

5.  Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

Authors:  Mohammed Eslam; Ahmed M Hashem; Reynold Leung; Manuel Romero-Gomez; Thomas Berg; Gregory J Dore; Henry L K Chan; William L Irving; David Sheridan; Maria L Abate; Leon A Adams; Alessandra Mangia; Martin Weltman; Elisabetta Bugianesi; Ulrich Spengler; Olfat Shaker; Janett Fischer; Lindsay Mollison; Wendy Cheng; Elizabeth Powell; Jacob Nattermann; Stephen Riordan; Duncan McLeod; Nicola J Armstrong; Mark W Douglas; Christopher Liddle; David R Booth; Jacob George; Golo Ahlenstiel
Journal:  Nat Commun       Date:  2015-03-05       Impact factor: 14.919

Review 6.  Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.

Authors:  S Chinnaswamy
Journal:  Genes Immun       Date:  2016-06-09       Impact factor: 2.676

7.  Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis.

Authors:  Nikolaos K Gatselis; Kalliopi Azariadis; Aggeliki Lyberopoulou; George N Dalekos
Journal:  J Transl Autoimmun       Date:  2021-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.